MedTrace Logo

A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer

NCT01919749 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-03-28

No results posted yet for this study

Summary

This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients.

Conditions

Interventions

OTHER

treated recommended

Treatment will be recommended after reviewing the profiling analysis

Sponsors & Collaborators

  • Side-Out Foundation

    collaborator OTHER

  • Translational Drug Development

    lead OTHER

Principal Investigators

  • Stephen Anthony, DO · Evergreen Hematology & Oncology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-08-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01919749 on ClinicalTrials.gov